OGN vs PEGA · P/E 3.4, rev $3.02B vs P/E 49, rev $850.7M
Organon & Co (OGN) versus Pegasystems Inc (PEGA) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Pegasystems Inc (PEGA) is a software - application company listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported PEGA revenue for 2026-06-30 was $850.7M. Net income was $46.1M. Revenue was up 97.8% from 2026-03-31 to 2026-06-30. PEGA currently screens at market cap $9.13B and trailing P/E 49.4.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. PEGA currently screens at market cap $9.13B and trailing P/E 49.4.
Not investment advice. Open the OGN and PEGA stock pages for the full models.
Not investment advice.